Searchable abstracts of presentations at key conferences in endocrinology

ea0011p595 | Neuroendocrinology and behaviour | ECE2006

Patients with pituitary disease who have had radiotherapy have reduced cerebral vasomotor reactivity

Rathbone N , Davies JS , Scanlon MF

Background and Aims: Studies have revealed increased vascular mortality, particularly cerebrovascular mortality in hypopituitary adults. Cranial radiotherapy has been implicated. This study was designed to assess the impact of cranial irradiation upon cerebrovascular function in patients with pituitary disease.Methods: Three groups were studied: - Group 1- (n=12), patients with pituitary disease who have had cranial radiotherapy, Group 2- (n</i...

ea0015p187 | Endocrine tumours and neoplasia | SFEBES2008

Adenosine stimulates secretion of chromogranin A in enterochromaffin cells

Kalhan Atul , Lewis BM , Scanlon MF , Rees DA , Ham Jack

Neuroendocrine tumours of the GI tract originate from enterochromaffin cells. Somatostatin analogues are the mainstay drugs for therapy in these cancers as they ameliorate symptoms and lower hormone secretion, but only in 30–70% of patients. Such tumours are also associated with angiogenesis which has been used as a prognostic indicator; adenosine, the major regulator of angiogenesis, is released by enhanced degradation of ATP, during cellular stress, damage and hypoxia.<...

ea0011oc31 | Diabetes and metabolism | ECE2006

Comparative analysis of the effects of dehydroepiandrosterone (DHEA) on white and brown pre-adipocyte proliferation/differentiation

Rice SPL , Wang E , Scanlon MF , Ludgate M , Rees DA

Dehydroepiandrosterone (DHEA) is an adrenal sex steroid whose levels decline during normal aging. Epidemiological studies demonstrate inverse correlation between circulating DHEA-sulphate and body fat mass while DHEA administration in elderly subjects reduces visceral and subcutaneous fat accumulation. Although previous studies have shown that some effects may be mediated via DHEA-induced inhibition of white pre-adipocyte proliferation, mechanisms remain unknown. Furthermore, ...

ea0011p119 | Clinical case reports | ECE2006

Cushing’s syndrome in an adolescent with MEN1: where is the lesion?

Smeeton F , Davies JS , Scanlon MF , Rees DA

A 14 year old girl, with a family history of MEN1, presented with secondary amenorrhoea and weight gain. Biochemical investigation revealed raised 24-hour urinary free cortisol excretions (1455, 1190, 614 nmol/24 hours; normal <290) and failure of cortisol suppression following 48 hours of low dose (0.5 mg qds) dexamethasone (199 nmol/l to 202 nmol/l). High dose dexamethasone administration (2 mg qds) for 48 hours resulted in further suppression of serum cortisol to 49 nmo...

ea0011p120 | Clinical case reports | ECE2006

Glucagonoma: does the clinical expression depend on the presence of inherited disease?

Smeeton F , Davies JS , Scanlon MF , Rees DA

A 40 year old gentleman presented with dramatic weight loss and a rash in the perineal area spreading to involve his face, trunk, legs and feet. Initial investigations demonstrated a normocytic anaemia with no evidence of thyroid disease or diabetes. Occasional diarrhoea prompted subsequent investigations including upper GI endoscopy, duodenal biopsy, pancreatic exocrine testing and barium follow-through studies which were normal. His 24 hour urinary 5-hydroxyindoleacetic acid...

ea0011p602 | Neuroendocrinology and behaviour | ECE2006

Complement C5a inhibits the secretion of macrophage migration inhibitory factor (MIF) in anterior pituitary cell lines

Lewis BM , Francis K , Monk P , Scanlon MF , Ham J

Complement C5a is associated with various pro-inflammatory effects such as chemotaxis, production of superoxides, histamine release, vasodilatation and smooth muscle contraction. In sepsis, excessive production of C5a can lead to multi-organ failure. C5a mediates its actions through the C5a receptor (C5aR) but may also bind to a second receptor called C5L2 that acts as a decoy for removing excess C5a. C5a is also rapidly cleaved to a less active form, C5adesR; C5L2, in contras...

ea0011oc7 | Signal transduction OC1 Novartis Oncology Young Investigator Award | ECE2006

The effect of bone marrow stem cell (BMSC) differentiation on growth hormone receptor (GHR)-associated signalling pathways

Lewis MD , Easter TE , Elford C , Ludgate ME , Evans BAJ , Rees DA , Scanlon MF

GH has diverse direct effects including the induction of lipolysis in adipocytes and mineralisation in bone. Interestingly, pluripotent mesenchymal stem cells can be isolated and cultured from adult bone marrow and induced to differentiate in vitro to both adipocytes and osteoblasts. GHR activation can be coupled to JAK2/STAT5 and the ERK (MAPK) pathway. We have therefore studied the evolution of GHR-associated cell signalling in adult rat BMSC’s during differentia...

ea0011p601 | Neuroendocrinology and behaviour | ECE2006

Adenosine stimulates connexin 43 expression and increases intercellular communication in the folliculostellate cells of the anterior pituitary gland

Lewis BM , Francis K , Pexa A , Deussen A , Scanlon MF , Rees DA , Ham J

We previously showed that adenosine stimulates IL-6 secretion from TtT/GF cells suggesting that adenosine is an important regulator of folliculostellate (FS) cell function. Gap-junction communication is also important for FS cell function so the aim of this study was to investigate the action of adenosine on connexin 43 (Cx 43) expression and intercellular communication.Adenosine production, as measured by reverse-phase fluorescent HPLC, was easily detec...

ea0011p677 | Reproduction | ECE2006

Impaired vascular function in hypogonadal males is unaltered during monthly treatment cycle with intramuscular testosterone esters

Lane HA , Smith jC , Morris K , Cockcroft J , Goodfellow J , Scanlon MF , Davies JS

Backround: Male hypogonadism is associated with an increased incidence of cardiovascular risk factors and approximately 25% of males suffering with coronary heart disease are hypogonadal. Few studies have assessed the impact of testosterone therapy on vascular function in hypogonadal individuals and none have investigated the weekly impact of gradually reducing testosterone concentrations on vasculature.Patients and Methods: 10 hypogonadal subjects (6 wi...